Table 2.

Immunophenotypic characterization of CD16+ and CD16– monocytes in the whole population of study participants

	CD16+	CD16−	ratio CD16+/CD16−	p
Cells/μl	52 ± 51	387 ± 134	0.14 ± 0.10	<0.001
% of total monocytes	11.4 ± 6.8	88.6 ± 6.8	0.14 ± 0.10	<0.001
FSC	557 ± 65	556 ± 63	1.0 ± 0.03	0.654
SSC	410 ± 53	481 ± 45	0.85 ± 0.06	<0.001
CD14	892 ± 558	2,384 ± 1,522	0.40 ± 0.17	<0.001
CD36	317 ± 138	740 ± 205	0.44 ± 0.15	<0.001
CD11b	82 ± 72	212 ± 301	0.59 ± 0.32	0.006

The median fluorescence intensities of CD14, CD36, and CD11b were assessed in each subset and expressed as fluorescence arbitrary units. Data are presented as means ± SD or as percentages, as appropriate. T test was used for the comparison of paired variables. Significant differences are given in italics.